Application

19084984 · TL1A-Binding Molecules, IL-23p19-Binding Molecules, and Bispecific Antigen-Binding Molecules, and Uses Thereof

Filed 2025-03-20 · Granted · Patent 12723093 (2026-09-01) The official file ↗The patent and its PDF ↗ · Art unit 1646 · Examiner Mark Halvorson Typical · CPC C07K 16/2875 · Newsoara Biopharmaceutical Technology (Suzhou) Co., Ltd. · DORITY & MANNING, P.A.

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

9.1 mo

to disposition 17.4 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.